Rasagiline Mesylate Transdermal Patch(world leader)

甲磺酸雷沙吉兰透皮贴剂(世领制药)

Report date: 2026/05/13 20:02:10

Base Information

Drug NameRasagiline Mesylate Transdermal Patch(world leader)
Drug Alias Name甲磺酸雷沙吉兰改良型AzilectAgilect
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitors
TargetsMonoamine oxidase B
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A